Zinc acetate lozenges for treating the common cold: an individual patient data meta‐analysis
dc.contributor.author | Hemilä, Harri | |
dc.contributor.author | Petrus, Edward J. | |
dc.contributor.author | Fitzgerald, James T. | |
dc.contributor.author | Prasad, Ananda | |
dc.date.accessioned | 2016-11-18T21:23:43Z | |
dc.date.available | 2018-01-08T19:47:52Z | en |
dc.date.issued | 2016-11 | |
dc.identifier.citation | Hemilä, Harri ; Petrus, Edward J.; Fitzgerald, James T.; Prasad, Ananda (2016). "Zinc acetate lozenges for treating the common cold: an individual patient data meta‐analysis." British Journal of Clinical Pharmacology 82(5): 1393-1398. | |
dc.identifier.issn | 0306-5251 | |
dc.identifier.issn | 1365-2125 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/134452 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | zinc acetate | |
dc.subject.other | common cold | |
dc.subject.other | meta‐analysis | |
dc.subject.other | randomized controlled trials | |
dc.subject.other | respiratory tract infections | |
dc.title | Zinc acetate lozenges for treating the common cold: an individual patient data meta‐analysis | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/134452/1/bcp13057-sup-0002-supplementary_material.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/134452/2/bcp13057_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/134452/3/bcp13057.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/134452/4/bcp13057-sup-0001-supplementary_material.pdf | |
dc.identifier.doi | 10.1111/bcp.13057 | |
dc.identifier.source | British Journal of Clinical Pharmacology | |
dc.identifier.citedreference | R Core Team ( 2015 ) R Project for Statistical Computing. Available at https://www.r‐project.org (accessed 19 July 2016). | |
dc.identifier.citedreference | Hemilä H, Chalker E. The effectiveness of high dose zinc acetate lozenges on various common cold symptoms: a meta‐analysis. BMC Fam Pract 2015; 16: 24. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359576 (accessed 19 July 2016). | |
dc.identifier.citedreference | Caruso TJ, Prober CG, Gwaltney JM. Treatment of naturally acquired common colds with zinc: a structured review. Clin Infect Dis 2007; 45: 569 – 574. | |
dc.identifier.citedreference | Science M, Johnstone J, Roth DE, Guyatt G, Loeb M. Zinc for the treatment of the common cold: a systematic review and meta‐analysis of randomized controlled trials. CMAJ 2012; 184: E551 – E561. | |
dc.identifier.citedreference | Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev 2013; CD001364. | |
dc.identifier.citedreference | Hemilä H. Zinc and the common cold: problems in the review by Caruso et al. (2007). 2013. Available at http://hdl.handle.net/10138/40817 (accessed 19 July 2016). | |
dc.identifier.citedreference | Hemilä H. Zinc acetate lozenges may shorten common cold duration by up to 40%. CMAJ eLetter May 28, 2012. Available at http://www.cmaj.ca/content/184/10/E551/reply#cmaj_el_706238 (accessed 19 July 2016). | |
dc.identifier.citedreference | Hemilä H. Concerns about unattributed copying of text and data, and about numerous other problems in the Cochrane review “Zinc for the Common Cold” by Singh M, Das RR (2013). 2015. Available at http://hdl.handle.net/10138/153180 (accessed 19 July 2016). | |
dc.identifier.citedreference | Singh M, Das RR. WITHDRAWN: Zinc for the common cold. Cochrane Database Syst Rev 2015; CD001364. | |
dc.identifier.citedreference | Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double‐masked, placebo‐controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy‐tested subjects. Curr Ther Res 1998; 59: 595 – 607. | |
dc.identifier.citedreference | Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate: a randomized, double‐blind, placebo‐controlled trial. Ann Intern Med 2000; 133: 245 – 252. | |
dc.identifier.citedreference | Prasad AS, Beck FW, Bao B, Snell D, Fitzgerald JT. Duration and severity of symptoms and levels of plasma interleukin‐1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis 2008; 197: 795 – 802. | |
dc.identifier.citedreference | Debray TP, Moons KG, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RH, et al. Get real in individual participant data (IPD) meta‐analysis: a review of the methodology. Res Synth Methods 2015; 6: 293 – 309. | |
dc.identifier.citedreference | Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003; 327: 557 – 560. | |
dc.identifier.citedreference | Godfrey JC, Conant‐Sloane B, Turco JH, Mercer N, Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992; 20: 234 – 246. | |
dc.identifier.citedreference | Mossad SB, Macknin ML, Medendorp SV, Mason P. Zinc gluconate lozenges for treating the common cold: a randomized, double‐blind, placebo‐controlled study. Ann Intern Med 1996; 125: 81 – 88. | |
dc.identifier.citedreference | Farr BM, Gwaltney JM Jr. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. J Chronic Dis 1987; 40: 875 – 879. | |
dc.identifier.citedreference | Pories WJ, Henzel JH, Rob CG, Strain WH. Acceleration of healing with zinc sulfate. Ann Surg 1967; 165: 432 – 436. | |
dc.identifier.citedreference | Simkin PA. Oral zinc sulphate in rheumatoid arthritis. Lancet 1976; 2: 539 – 542. | |
dc.identifier.citedreference | Lyckholm L, Heddinger SP, Parker G, Coyne PJ, Ramakrishnan V, Smith TJ, et al. A randomized, placebo controlled trial of oral zinc for chemotherapy‐related taste and smell disorders. J Pain Palliat Care Pharmacother 2012; 26: 111 – 114. | |
dc.identifier.citedreference | Bamford JT, Gessert CE, Haller IV, Kruger K, Johnson BP. Randomized, double‐blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea. Int J Dermatol 2012; 51: 459 – 462. | |
dc.identifier.citedreference | Eby GA, Davis DR, Halcomb WW. Reduction in duration of common cold by zinc gluconate lozenges in a double‐blind study. Antimicrob Agents Chemother 1984; 25: 20 – 4. | |
dc.identifier.citedreference | Hemilä H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011; 5: 51 – 58. | |
dc.identifier.citedreference | Godfrey JC. Zinc for the common cold. Antimicrob Agents Chemother 1988; 32: 605 – 606. | |
dc.identifier.citedreference | Eby GA. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep 2004; 24: 23 – 39. | |
dc.identifier.citedreference | Eby GA. Zinc lozenges as cure for the common cold ‐ a review and hypothesis. Med Hypotheses 2010; 74: 482 – 492. | |
dc.identifier.citedreference | Zarembo JE, Godfrey JC, Godfrey NJ. Zinc(II) in saliva: determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. J Pharm Sci 1992; 81: 128 – 130. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.